Compugen monetizes royalties to AstraZeneca for up to $90 million

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Compugen monetizes royalties to AstraZeneca for up to $90 million

Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million

December 17, 2025 7:00 AM EST

Non-dilutive strategic transaction expected to extend cash runway into 2029, to advance Compugen's innovative immuno-oncology pipeline and to reach potential key catalysts from internal and partnered programsMonetization includes an upfront payment of $65 million and a potential additional $25 million upon reaching the next milestoneCompugen retains majority of royalties preserving potential significant long-term upside reflecting its belief in the potential of... More